Literature DB >> 26460183

Detection of neuraminidase stalk motifs associated with enhanced N1 subtype influenza A virulence via Raman spectroscopy.

JooYoung Choi1, Sharon J H Martin1, Ralph A Tripp2, S Mark Tompkins2, Richard A Dluhy1.   

Abstract

Oligonucleotides corresponding to neuraminidase (NA) stalk motifs that have been associated with enhanced influenza virulence have been identified using surface-enhanced Raman spectroscopy (SERS). 5'-Thiolated ssDNA oligonucleotides were immobilized onto a hexadecyltrimethylammonium bromide (CTAB) coated Au nanoparticles (AuNP). Three synthetic RNA sequences corresponding to specific amino acid deletions in the influenza NA stalk region were attached to the CTAB-modified AuNPs. Two of these sequences were specific to sequences with amino acid deletions associated with increased virulence, and one was a low virulence sequence with no amino acid deletions. Hybridization of synthetic matched and mismatched DNA-RNA complexes were detected based on the intrinsic SERS spectra. In addition, this platform was used to analyze RNA sequences isolated from laboratory grown influenza viruses having the NA stalk motif associated with enhanced virulence, including A/WSN/33/H1N1, A/Anhui/1/2005/H5N, and A/Vietnam/1203/2004/H5N1 strains. Multivariate feature selection methods were employed to determine the specific wavenumbers in the Raman spectra that contributed the most information for class discrimination. A one-way analysis of variance (ANOVA) test identified 884 and 1196 wavenumbers as being highly significant in the high and low virulence spectra, respectively (p < 0.01). A post-hoc Tukey Honestly Significance Difference (HSD) test identified the wavenumbers that played a major role in differentiating the DNA-RNA hybrid classes. An estimate of the spectral variability, based on the Wilcoxon rank sum test, found the major source of variation to be predominately between the different classes, and not within the classes, thus confirming that the spectra reflected real class differences and not sampling artifacts. The multivariate classification methods partial least squares discriminant analysis (PLS-DA) and support vector machine discriminant analysis (SVM-DA) were able to distinguish between different NA stalk-motifs linked to NA-enhanced influenza virus virulence (NA-EIV) with >95% sensitivity and specificity in both synthetic RNA sequences as well as the isolated viral RNA. This study demonstrates the feasibility of SERS for direct identification of influenza NA stalk mutations associated with virulence without sample amplification or labeling.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26460183      PMCID: PMC4687448          DOI: 10.1039/c5an00977d

Source DB:  PubMed          Journal:  Analyst        ISSN: 0003-2654            Impact factor:   4.616


  29 in total

1.  Label-free SERS detection of microRNA based on affinity for an unmodified silver nanorod array substrate.

Authors:  Jeremy D Driskell; Ralph A Tripp
Journal:  Chem Commun (Camb)       Date:  2010-03-24       Impact factor: 6.222

2.  Chemically bound gold nanoparticle arrays on silicon: assembly, properties and SERS study of protein interactions.

Authors:  Agnieszka Kaminska; Obianuju Inya-Agha; Robert J Forster; Tia E Keyes
Journal:  Phys Chem Chem Phys       Date:  2008-06-05       Impact factor: 3.676

3.  Quantitative surface-enhanced Raman spectroscopy based analysis of microRNA mixtures.

Authors:  Jeremy D Driskell; Oliva M Primera-Pedrozo; Richard A Dluhy; Yiping Zhao; Ralph A Tripp
Journal:  Appl Spectrosc       Date:  2009-10       Impact factor: 2.388

4.  An ionic surfactant-mediated Langmuir-Blodgett method to construct gold nanoparticle films for surface-enhanced Raman scattering.

Authors:  Prompong Pienpinijtham; Xiao Xia Han; Sanong Ekgasit; Yukihiro Ozaki
Journal:  Phys Chem Chem Phys       Date:  2012-06-26       Impact factor: 3.676

Review 5.  Role of hemagglutinin cleavage for the pathogenicity of influenza virus.

Authors:  D A Steinhauer
Journal:  Virology       Date:  1999-05-25       Impact factor: 3.616

6.  Alterations of the stalk of the influenza virus neuraminidase: deletions and insertions.

Authors:  G Luo; J Chung; P Palese
Journal:  Virus Res       Date:  1993-08       Impact factor: 3.303

7.  Comparison of linear and nonlinear classification algorithms for the prediction of drug and chemical metabolism by human UDP-glucuronosyltransferase isoforms.

Authors:  Michael J Sorich; John O Miners; Ross A McKinnon; David A Winkler; Frank R Burden; Paul A Smith
Journal:  J Chem Inf Comput Sci       Date:  2003 Nov-Dec

8.  Characterization of low-pathogenicity H5N1 avian influenza viruses from North America.

Authors:  Erica Spackman; David E Swayne; David L Suarez; Dennis A Senne; Janice C Pedersen; Mary Lea Killian; John Pasick; Katherine Handel; Smitha P Somanathan Pillai; Chang-Won Lee; David Stallknecht; Richard Slemons; Hon S Ip; Tom Deliberto
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

9.  Neuraminidase stalk length and additional glycosylation of the hemagglutinin influence the virulence of influenza H5N1 viruses for mice.

Authors:  Yumiko Matsuoka; David E Swayne; Colleen Thomas; Marie-Anne Rameix-Welti; Nadia Naffakh; Christine Warnes; Melanie Altholtz; Ruben Donis; Kanta Subbarao
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

10.  Genome-sequence analysis of the pathogenic H5N1 avian influenza A virus isolated in China in 2004.

Authors:  Hongbo Zhou; Meilin Jin; Huanchun Chen; Qinfeng Huag; Zhengjun Yu
Journal:  Virus Genes       Date:  2006-02       Impact factor: 2.332

View more
  2 in total

1.  Label-Free Detection of Glycan-Protein Interactions for Array Development by Surface-Enhanced Raman Spectroscopy (SERS).

Authors:  Xiuru Li; Sharon J H Martin; Zoeisha S Chinoy; Lin Liu; Brandon Rittgers; Richard A Dluhy; Geert-Jan Boons
Journal:  Chemistry       Date:  2016-06-30       Impact factor: 5.236

2.  Inhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1 influenza virus.

Authors:  Yinghua Li; Zhengfang Lin; Min Guo; Yu Xia; Mingqi Zhao; Changbing Wang; Tiantian Xu; Tianfeng Chen; Bing Zhu
Journal:  Int J Nanomedicine       Date:  2017-08-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.